Ticker Details
Vor Biopharma Inc. Common Stock
IPO Date:	February 1, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$776.48M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.42 | 4.62%
Avg Daily Range (30 D):	$0.51 | 3.33%
Avg Daily Range (90 D):	$0.61 | 4.12%

Institutional Daily Volume
Avg Daily Volume:	1.31M
Avg Daily Volume (30 D):	.87M
Avg Daily Volume (90 D):	.88M

Trade Size
Avg Trade Size (Sh.):	306
Avg Trade Size (Sh.) (30 D):	82
Avg Trade Size (Sh.) (90 D):	88

Institutional Trades
Total Institutional Trades:	200
Avg Institutional Trade:	$2M
Avg Institutional Trade (30 D):	$1.03M
Avg Institutional Trade (90 D):	$1.62M
Avg Institutional Trade Volume:	.07M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.75M
Avg Closing Trade (30 D):	$.92M
Avg Closing Trade (90 D):	$1.64M
Avg Closing Volume:	90.22K

News

Apr 1, 2026 @ 9:00 PM Vor Bio Reports Inducement Grant Under Nasdaq List... Source: Na

Nov 11, 2025 @ 2:56 AM Vor Bio Announces Pricing of Public Offering of $1... Source: Vor Biopharma Inc.

Nov 8, 2025 @ 4:45 PM Telitacicept Achieved Primary Endpoint of Reducing... Source: Vor Bio

Oct 31, 2025 @ 8:30 PM Vor Bio Reports Inducement Grants Under Nasdaq Lis... Source: Carl Mauch And Sarah Spencer

Aug 18, 2025 @ 8:35 PM Vor Bio Reports Inducement Grants Under Nasdaq Lis... Source: Vor Bio

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$168.31	$-5.11	$307.61
Diluted EPS	$168.31	$-5.11	$307.61
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-883.08M	$-219.59M	$1.72B
Operating Income / Loss	$-373.51M	$-35.16M	$-35.96M
Cost of Revenue
Net Cash Flow	$117.58M	$-226.61M	$236.02M
PE Ratio

Splits
Sep 19, 2025	1:20